AU2003267992A1 - Mycoplasma gallisepticum formulation - Google Patents

Mycoplasma gallisepticum formulation

Info

Publication number
AU2003267992A1
AU2003267992A1 AU2003267992A AU2003267992A AU2003267992A1 AU 2003267992 A1 AU2003267992 A1 AU 2003267992A1 AU 2003267992 A AU2003267992 A AU 2003267992A AU 2003267992 A AU2003267992 A AU 2003267992A AU 2003267992 A1 AU2003267992 A1 AU 2003267992A1
Authority
AU
Australia
Prior art keywords
mycoplasma gallisepticum
formulation
gallisepticum formulation
mycoplasma
gallisepticum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267992A
Other languages
English (en)
Other versions
AU2003267992A8 (en
Inventor
Naola Ferguson
Stanley H. Kleven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc filed Critical University of Georgia Research Foundation Inc
Publication of AU2003267992A1 publication Critical patent/AU2003267992A1/en
Publication of AU2003267992A8 publication Critical patent/AU2003267992A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003267992A 2002-07-13 2003-07-10 Mycoplasma gallisepticum formulation Abandoned AU2003267992A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/194,180 US7217420B2 (en) 2002-07-13 2002-07-13 Mycoplasma gallisepticum formulation
US10/194,180 2002-07-13
PCT/US2003/022011 WO2004006851A2 (en) 2002-07-13 2003-07-10 Mycoplasma gallisepticum formulation

Publications (2)

Publication Number Publication Date
AU2003267992A1 true AU2003267992A1 (en) 2004-02-02
AU2003267992A8 AU2003267992A8 (en) 2004-02-02

Family

ID=30114683

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267992A Abandoned AU2003267992A1 (en) 2002-07-13 2003-07-10 Mycoplasma gallisepticum formulation

Country Status (11)

Country Link
US (2) US7217420B2 (https=)
EP (1) EP1531861A4 (https=)
JP (1) JP2005533116A (https=)
KR (1) KR20050074428A (https=)
CN (1) CN1688336A (https=)
AU (1) AU2003267992A1 (https=)
BR (1) BR0312640A (https=)
MX (1) MXPA05000467A (https=)
RU (1) RU2005104100A (https=)
WO (1) WO2004006851A2 (https=)
ZA (1) ZA200500169B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080026386A1 (en) * 2006-03-31 2008-01-31 Behrens Timothy W Irf-5 haplotypes in systemic lupus erythematosus
TWI422594B (zh) * 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) * 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137306A (en) 1966-07-11 1968-12-18 Research Corp Inoculum for poultry
JPS52134019A (en) 1976-04-28 1977-11-09 Biseibutsu Kagaku Kenkiyuushiy Micoplasma galicepticum infection vaccine
US5004607A (en) 1987-08-25 1991-04-02 University Of Georgia Research Foundation, Inc. Method of immunizing poultry
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
CA1339260C (en) 1988-06-02 1997-08-12 Kazumi Kodama Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
WO1993024646A1 (fr) 1992-05-29 1993-12-09 Nippon Zeon Co., Ltd. Antigene de mycoplasme aviaire, son gene, vecteur recombine contenant ledit gene, et vaccin prepare a l'aide de celui-ci
AU691175B2 (en) 1993-03-31 1998-05-14 Nippon Zeon Co., Ltd. Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
ATE196773T1 (de) 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
JPH07133295A (ja) 1993-08-27 1995-05-23 Nippon Zeon Co Ltd 新規な抗原タンパク質、その遺伝子、及び組み換えバキュロウイルスとその利用
JPH07228542A (ja) 1994-02-18 1995-08-29 Nippon Seibutsu Kagaku Kenkyusho 不活化病原体の鶏用気管内投与ワクチン
EP0802796B1 (en) 1995-01-06 2001-10-04 Akzo Nobel N.V. Chicken anaemia agent broiler vaccine
ZA978434B (en) 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.

Also Published As

Publication number Publication date
ZA200500169B (en) 2006-06-28
BR0312640A (pt) 2005-06-28
EP1531861A4 (en) 2006-10-11
WO2004006851A2 (en) 2004-01-22
KR20050074428A (ko) 2005-07-18
EP1531861A2 (en) 2005-05-25
US7217420B2 (en) 2007-05-15
US20040009179A1 (en) 2004-01-15
JP2005533116A (ja) 2005-11-04
AU2003267992A8 (en) 2004-02-02
WO2004006851A3 (en) 2004-03-18
US20060257414A1 (en) 2006-11-16
CN1688336A (zh) 2005-10-26
MXPA05000467A (es) 2005-09-30
RU2005104100A (ru) 2005-08-27

Similar Documents

Publication Publication Date Title
AU2002327094A1 (en) Cosmetics
AU2003300596A1 (en) Cosmetic composition comprising a polymer
AU2003284401A1 (en) Cosmetic composition
AU2003241882A1 (en) Applicator
AU2003280797A1 (en) Shampoo composition
EP1542656A4 (en) ANTIBIOTIC PRODUCT, USE AND FORMULATION THEREOF
AU2003218121A1 (en) Lotion compositions
AU2003227419A1 (en) Latex composition
AU2003267409A1 (en) Make-up device
GB0207438D0 (en) Formulation
AU2003226487A1 (en) Formulation
AU2003280431A1 (en) Immunogenic mycoplasma hyopneumoniae polypeptides
AU2002258529A1 (en) Antioxidant dermatological composition
AU2003267992A1 (en) Mycoplasma gallisepticum formulation
AU2003217110A1 (en) Novel formulation
AU2003248263A1 (en) Cosmetic
AU2003241537A1 (en) Biguanide formulations
AU2003301902A1 (en) Cosmetic compositions
AUPS019802A0 (en) Nutrient formulation
AU2002358337A1 (en) Novel retinol derivative and cosmetic composition comprising the same
AU2003301901A1 (en) Cosmetic composition
AU2003255990A1 (en) Anti-wrinkles cosmetic compositions
AU2003278950A1 (en) Dilator
AU2003303900A1 (en) Cosmetic composition based on cirsimarin
HK1076129A (en) Immunogenic mycoplasma hyopneumoniae polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase